CLINICAL TREATMENT GUIDE | USA

Fibromyalgia Management

Fibromyalgia management in the United States has shifted towards centralized pain modulation. It is no longer viewed as a 'muscle' condition but as a 'nervous system volume' disorder.

The Central Sensitization Model

U.S. clinical consensus describes fibromyalgia as 'central sensitization,' where the brain and spinal cord amplify pain signals. Treatments focus on calming the overactive nervous system rather than treating localized inflammation.

FDA-Approved Triple Therapy

Only three drugs are specifically FDA-indicated for fibromyalgia in the United States: Lyrica (Pregabalin), Cymbalta (Duloxetine), and Savella (Milnacipran). Most other treatments are used off-label by specialists.

Medication Options for Fibromyalgia

Frequently Asked Questions

Is fibromyalgia a type of arthritis?

No. Unlike arthritis, fibromyalgia does not cause joint damage or inflammation. It is a neurological pain processing disorder.

Why isn't ibuprofen helpful?

Fibromyalgia is not an inflammatory condition, so NSAIDs like ibuprofen typically provide minimal relief compared to nerve-modulating drugs.

Last Updated: March 5, 2026

Medical Disclaimer: This guide centers on Fibromyalgia management within the United States. It is not a substitute for professional medical advice. Always consult your healthcare provider regarding specific treatments for persistent pain.